Growth Metrics

Canton Strategic Holdings (CNTN) Income towards Parent Company (2021 - 2026)

Canton Strategic Holdings posted quarterly Income towards Parent Company of -$47.3 million for Q1 2026, down 1762.66% year-on-year from $2.8 million in Q1 2025, and down 1939.47% on a QoQ basis from -$2.3 million in Q4 2025.

Canton Strategic Holdings (CNTN) has 6 years of Income towards Parent Company data on file, last reported at -$47.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company fell 1762.66% year-over-year to -$47.3 million; the trailing twelve-month figure through Mar 2026 stood at -$53.6 million (down 330.72% YoY), and the FY2025 full-year result was -$35.9 million, down 194.45% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$47.3 million, down from -$2.3 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$1.6 million in Q2 2022 and bottomed at -$47.3 million in Q1 2026.
  • The 5-year median for Income towards Parent Company is -$2.3 million (2024), against an average of -$5.1 million.
  • The widest annual swing landed in 2025, when Income towards Parent Company soared 44.63%; it then plunged 1762.66% in 2026.
  • A 5-year view of Income towards Parent Company shows it stood at -$1.8 million in 2022, then slumped by 40.74% to -$2.5 million in 2023, then sank by 53.08% to -$3.8 million in 2024, then surged by 38.7% to -$2.3 million in 2025, then tumbled by 1939.47% to -$47.3 million in 2026.
  • The last three Income towards Parent Company figures came in at -$47.3 million (Q1 2026), -$2.3 million (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Canton Strategic Holdings 643.89 Mn 602.36 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -47.34 Mn
Dec 31, 2025 -2.32 Mn
Sep 30, 2025 -2.10 Mn
Jun 30, 2025 -1.86 Mn
Mar 31, 2025 -2.54 Mn
Dec 31, 2024 -3.79 Mn
Sep 30, 2024 -3.80 Mn
Jun 30, 2024 -2.33 Mn
Mar 31, 2024 -2.26 Mn
Dec 31, 2023 -2.47 Mn
Sep 30, 2023 -1.82 Mn
Jun 30, 2023 -2.34 Mn
Mar 31, 2023 -2.69 Mn
Dec 31, 2022 -1.76 Mn
Sep 30, 2022 -2.13 Mn
Jun 30, 2022 -1.64 Mn
Mar 31, 2022 -2.95 Mn
Dec 31, 2021 -359,593.00
Sep 30, 2021 -777,113.00
Jun 30, 2021 -1.29 Mn
Mar 31, 2021 -1.62 Mn